Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients

Inclusion Criteria

• •Patient has been administering latanoprost eye drops in affected eye(s) for at least 12 weeks prior to study
• •Patient must have at least partially responded to latanoprost and requiring further IOP lowering eye drops
• •Diagnosis of chronic angle-closure glaucoma
• •Patients using COMBIGAN® in the past must not have been discontinued due to adverse events or lack of efficacy.